EMILY ALCE: Open Payments
NPI 1306245576 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 30 payments from 6 companies in 2025. Trend: 2023 $992 · 2024 $1,438 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $590 |
| Currax Pharmaceuticals LLC | 5 | $82 |
| Dexcom, Inc. | 4 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| VIVUS LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: Wegovy, Ozempic, CONTRAVE, Dexcom G6 Transmitter, LEQVIO, QSYMIA.
Industry payments across GA — which companies pay providers there.
